Steven Cohen’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
Other funds holding CTKB
Steven Cohen's CTKB Position: Q3 2026 in Review
Steven Cohen reduced its Cytek Biosciences (CTKB) stake by 95% in Q3 2026, selling an estimated $1.9M and leaving 22,593 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #3593.
Steven Cohen first reported a position in CTKB in Q1 2022 and has held it in 10 quarters since. The position peaked at $16.5M in Q2 2022. 152 funds tracked by Wall St. Rank hold CTKB as of Q3 2026.
- Steven Cohen held 22,593 shares of Cytek Biosciences worth $135K as of Q3 2026.
- Steven Cohen sold 399,768 Cytek Biosciences shares in Q3 2026, an estimated $1.9M.
- Cytek Biosciences made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3593 holding.
- Steven Cohen first reported a position in Cytek Biosciences in Q1 2022 and has held it in 10 quarters since.
- Steven Cohen's Cytek Biosciences position peaked at $16.5M in Q2 2022.
- 152 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.